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Membrane microdomainThe role of iron in oxidative injury in the nervous system has been extensively described. However, little is
known about the role of lipid signal transduction in neurodegeneration processes triggered by iron overload.
The purpose of this work was to characterize the regulation and the crosstalk between phosphatidylcholine
(PC)-derived diacylglycerol (DAG) and cannonical signaling pathways during iron-induced oxidative stress
in cerebral cortex synaptic endings (Syn) obtained from adult (4 months old) and aged (28 months old)
rats. DAG production was increased in Syn exposed to iron. This rise in DAG formation was due to phospho-
lipase D1 (PLD1) and PLD2 activations. In adult rats, PKD1, ERK1/2 and PKCα/βII activations were PLD1 and
PLD2 dependent. In contrast, in senile rats, DAG formation catalyzed by PLDs did not participate in PKD1,
ERK1/2 and PKCα/βII regulations, but it was dependent on ERK and PKC activities. Iron-induced oxidative
stress promoted an increased localization of PLD1 in membrane rafts, whereas PLD2 was excluded from
these domains and appeared to be involved in glutamate transporter function. Our results show a differential
regulation and synaptic function of DAG generated by PLDs during iron-induced oxidative stress as a conse-
quence of aging.
© 2012 Elsevier B.V. All rights reserved.1. Introduction
Phosphatidylcholine (PC) is the most abundant class of
glycerophospholipids in mammalian cell membranes and it plays a
key role in membrane structure, cell death, and cellular signaling. In
regard to signal transduction, PC is the main substrate for phospholipase
D (PLD), yielding phosphatidic acid (PA) and choline upon cleavage [1,2].
PA generated by PLD can be further hydrolyzed by lipid phosphate
phosphatases (LPPs) in order to generate another lipid secondmessenger,
diacylglycerol (DAG).
To date, two isoforms of mammalian PC-speciﬁc PLD (PLD1 and
PLD2) have been cloned [3–5]. They share about 50% amino acid similar-
ity, but exhibit quite different regulatory properties. PLD1 (120 kDa) has
a low basal activity and responds to protein kinase C (PKC) and tomem-
bers of the Rho and ARF families of small G proteins. PLD2, in contrast,
exhibits a higher basal activity and presents a molecular weight of
100 kDa [1,2,6]. Involvement of PLD pathway has been proposed in
several cellular events such as cytoskeletal rearrangement, vesicle
trafﬁcking, exocytosis, phagocytosis, oncogenesis, and neuronal and
cardiac stimulation [6]. In the nervous system, PLD isoforms are present
in neurons (independent of their transmitter) as well as in glial cellss Bioquímicas de Bahía Blanca,
ca and Universidad Nacional
000 Bahía Blanca, Argentina.
r).
l rights reserved.(astrocytes and oligondendrocytes) where they contribute to speciﬁc
functions in e.g. cellular proliferation, exo- and endocytosis and neurite
formation [6].
In healthy brains, iron levels are strictlymaintained through highly
regulated mechanisms of uptake, storage, and secretion. The ability of
non-chelatable iron to accept and donate electrons leads to the forma-
tion of reactive nitrogen and oxygen species (RNS and ROS, respec-
tively). These reactive species may trigger the oxidative attack of
tissue components, causing brain lipid peroxidation, protein and
DNA oxidation, impairment of membrane ion-motive ATPases, glu-
cose and glutamate transport and mitochondrial function, thus con-
tributing to disease and perhaps aging itself [7–9]. In neurons,
synapses are siteswhere the ﬁrstmanifestations of neurodegenerative
processes are likely to appear, and their vulnerability to iron-induced
oxidative stress has been largely demonstrated by the presence of
membrane lipid peroxidation, impairment of glucose and glutamate
transport, and mitochondrial function [7,10–12]. The accumulation
of transition metals (like iron) in the nervous system is a common ob-
servation in different neurodegenerative diseases, such as Parkinson's
disease (PD), Alzheimer's disease (AD), Huntington's disease (HD) as
well as amyotrophic lateral sclerosis (ALS) [13–15]. A large number
of studies have demonstrated that metal-induced oxidative stress is
one common feature in the onset of these neurodegenerative diseases
[8,14].
Though a number of reports have described the intracellular
events triggered by oxidative stress, very little is known about the
role of lipid signal transduction during oxidative injury [16]. In line
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scribed in cardiomyocites and PC12 cells [17,18]. Previous studies
from our lab concluded that oxidative stress triggered by free iron en-
hances DAG generation from PC in synaptic endings (Syn) isolated
from the cerebral cortex of adult and aged rats, and that this genera-
tion is in part due to the activation of PLD/LPP pathway [11]. We also
demonstrated that both isoforms (PLD1 and PLD2) are present in Syn
from adult and aged rats [19].
In view of the above, the aim of the present work is to address the
role of PLD1 and PLD2 in synaptic DAG formation and in the activa-
tion of signal transduction pathways elicited by iron-induced oxida-
tive stress, such as protein kinase D (PKD1), PKC and extracellular
signal-regulated kinase (ERK) pathways. Furthermore, we explored
the status of these signaling pathways in Syn obtained from aged
animals.
2. Materials and methods
Wistar-INIBIBB strain adult (4 months old) andaged (24–28 months
old) ratswere kept under constant environmental conditions (24 °C and
12 h–12 h light–dark cycles) and fed on a standard pellet diet ad
libitum. All proceedings were in accordance with Principles of Use of
Animals and Guide for the Care and Use of Laboratory Animals (NIH regu-
lation). Rats (males and females) were killed by using a CO2 chamber.
After death, rats were decapitated and cerebral cortices were immedi-
ately dissected (1–2 min after death) at 4 °C.
1-[14C]palmitoyl-2-[14C]palmitoyl-sn-glycero-3-phosphocholine
([14C]-DPPC) (111 mCi/mmol), aminobutyric acid γ-[1-14C] ([14C]-
GABA) (49.41 mCi/mmol) and glutamic acid, L-[3,4-3H] ([3H]-gluta-
mate) (49,6 Ci/mmol) were purchased from New England Nuclear-
Dupont, Boston, MA, USA. Preblended dry ﬂuor 2a70 (98% PPO and
2% bis-MSB) was obtained from Research Products International
Corp. (Mount Prospect, IL, USA). Triton X-100 (octyl phenoxy
polyethoxyethanol), dimethyl sulfoxide (DMSO), 1,4-diamino-2,3-
dicyano-1,4-bis[2-aminophenylthio]butadiene (U0126), Bisindolyl-
maleimide I (BIM), Chelerythrine chloride, Staurosporine, Phorbol
12-myristate 13-acetate (PMA) and thiobarbituric acid (TBA)
were obtained from Sigma-Aldrich (St. Louis, MO, USA). (1R,2R)-
N-([S]-1-{4-[5-bromo-2-oxo-2,3-dihydro-1H-benzo(d)imidazol-1-
yl]piperidin-1-yl}propan-2-yl)-2-phenylcyclopropanecarboxamide
(VU0359595 or EVJ), N-{2-[4-oxo-1-phenyl-1,3,8-triazaspiro(4.5)
decan-8-yl]ethyl}quinoline-3-carboxamide (VU0285655-1 or APV)
and 1,2-dioctanoyl-sn-glycerol (DOG) were from Avanti Polar Lipids,
Inc. (Alabaster, AL, USA). The kit (Colestat enzimático AA) for mea-
suring cholesterol was fromWiener laboratory (Rosario, Argentina).
The kit for measuring protein content (DC protein assay) was from
Bio-Rad Life Science group. Rabbit polyclonal antibodies anti-PKD1
(#2052), anti-Phospho-PKD1 (Ser744/728) (#2054), anti-ERK1/2
(#9102), anti-Phospho-ERK1/2 (#9101), anti-Phospho-PKCα/βII
(Thr638/641) (#9375), anti-Phospho-PKCδ (Thr505) (#9374) and
anti-PLD1 (#3832) were from Cell Signaling (Beverly, MA, USA).
Mouse monoclonal anti-PKCα (#610107) and anti-PKCδ (#610397)
were from BD Biosciences (San Jose, CA, USA). Rabbit polyclonal
anti-Flotillin-1 antibody (sc-25506), goat polyclonal anti-PLD2 anti-
body (sc-48269), polyclonal horse radish peroxidase (HRP)-conjugated
goat anti-rabbit IgG and polyclonal HRP-conjugated goat anti-mouse
IgG were purchased from Santa Cruz Biotechnology, Inc. (Santa Cruz,
CA, USA). All other chemicals were of the highest purity available.
2.1. Preparation of synaptosomal fraction
Total homogenates were prepared from the cerebral cortex (CC) of
4 month-old (adults) and 24–28 month-old (aged) rats. The same
number of cortices frommale and female rats was used in each experi-
ment. Synaptosomes representing synaptic endings (Syn) were
obtained as previously described by Cotman with slight modiﬁcations[19,20]. Brieﬂy, CC homogenate (20%, w/v) was prepared in a medium
containing 0.32 M sucrose, 1 mM EDTA, and 10 mM HEPES buffer
(pH 7.4) in the presence of 1 mM DTT, 2 μg/ml leupeptin, 1 μg/ml
aprotinin, 1 μg/ml pepstatin, and 0.1 mM PMSF. The CC was homoge-
nized by 10 strokes with a Thomas tissue homogenizer. The homoge-
nate was centrifuged at 1800 g for 7.5 min at 4 °C using a JA-21 rotor
in a Beckman J2-21 centrifuge. The pellet was discarded and the super-
natant was retained and centrifuged at 15,000 g for 20 min at 4 °C. The
resulting pellet waswashed and resuspended in 2 ml of 0.32 M sucrose
isolation buffer, layered over a discontinuous Ficoll gradient (4 ml of
8.5% pH 7.4, 4 ml of 13% pH 7.4 Ficoll solutions, each prepared in isola-
tion buffer) and spun at 100,000 g for 30 min at 4 °C using a SW 41
rotor in a Beckman Optima LK-90 ultracentrifuge. Syn in the 8.5%–13%
Ficoll interface were removed, resuspended in isolation buffer, and
centrifuged at 33,000 g for 20 min at 4 °C using a JA-21 rotor in a
Beckman J2-21 centrifuge. For the experiments, synaptosomes were
diluted in Tris base buffer medium (TBM) containing 120 mM NaCl,
5.0 mM KCl, 1.0 mM MgCl2, 5 mM NaHCO3, 1.2 mM Na2HPO4, 10 mM
glucose, 20 mM Tris (pH 7.2), and protein content was determined by
a previously published method [21] using the kit DC protein assay
from Bio-Rad.
2.2. Experimental treatments
Syn were diluted in TBM, the suspension was aliquoted into tubes
and incubated at 37 °C under an O2:CO2 (95:5, v/v) atmosphere during
experimental treatments. Oxidative stress was induced by incubating
Syn with 50 μM FeSO4 for 1 or 2 h as previously described [11]. FeSO4
was prepared as a 10 mM stock in ultrapure water immediately prior
to use and the samevolume of ultrapurewaterwas added to the control
condition.
To study the role of PLD isoforms, Syn were preincubated with 2%
ethanol (EtOH), 0.15 μM EVJ (PLD1 inhibitor), 0.5 μM APV (PLD2 in-
hibitor) or Vehicle (DMSO 0.0025%) for 10 min at 37 °C before iron
treatment. To study the role of PKC, Syn were preincubated with
1 μM PMA, 10 μM BIM, 0.1 μM Staurosporine, 5 μM Chelerythrine or
vehicle (DMSO 0.0025%) for 10 min at 37 °C before iron treatment.
To study the role of the MEK/ERK1/2 pathways, Syn were
preincubated for 10 min at 37 °C in the presence of the MEK inhibitor
U0126 (25 μM). To study the activation of ERK1/2 by exogenous DAG,
Syn were treated with 0, 5 or 100 μM of DOG for 2 h at 37 °C.
2.3. Isolation of detergent-resistant membranes (DRMs)
DRMs were isolated from the entire Syn exposed to 50 μM FeSO4 or
to ultrapure water for 1 h. DRM fractionwas isolated following the pro-
cedure previously described by Brown and Rose with slight modiﬁca-
tions to our experimental system [19,22]. Brieﬂy, the synaptosomal
pellet obtained from 2 CC was resuspended in 1.6 ml of iced-cold
(0–4 °C) lysis buffer consisting of 1% Triton X-100 in DRM buffer
(10 mM Tris–HCl (pH 7.4), 70 mM NaCl, 2 mM MgCl2 and 0.5 mM
EDTA) with protease inhibitors added (1 mM DTT, 2 μg/ml leupeptin,
1 μg/ml aprotinin, 1 μg/ml pepstatin, and 0.1 mM PMSF). The suspen-
sion was homogenized by passing it through a 21 G×1 1/2″ needle
4–5 times and it was incubated at 4 °C for 30 min. The homogenization
was repeated after 15 min of incubation. The homogenate was subse-
quently centrifuged at 1000 g for 15 min at 4 °C (2500 rpm, Beckman
JA-21 rotor, Beckman J2-21 centrifuge). The supernatant was diluted
1:1 in 80% (w/v) sucrose, divided into two samples and placed at the
bottom of ultracentrifuge tubes. Additionally, 6.6 ml of 30% (w/v) su-
crose was layered, followed by 2.6 ml 5% (w/v) sucrose. All the sucrose
solutions were handled at 0–4 °C and diluted in the DRM buffer (with-
out Triton X-100) containing protease inhibitors (1 mM DTT, 2 μg/ml
leupeptin, 1 μg/ml aprotinin, 1 μg/ml pepstatin, and 0.1 mM PMSF).
Samples were centrifuged for 20 h at 120,000 g (Beckman SW 41
rotor in a Beckman Optima LK-90 ultracentrifuge) at 4 °C. After the
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pellet were obtained. The band containing the DRMs was present in
the 5–30% sucrose interface. The fractions were collected and trans-
ferred to a new centrifuge tube, which was ﬁlled up with DRM buffer
and centrifuged for 1 h at 120,000 g in a Beckman 90Ti rotor using a
Beckman Optima LK-90 ultracentrifuge. The following pellets were
resuspended in TBM buffer and protein content was determined by a
previously published method [21] using the DC protein assay kit from
Bio-Rad.
2.4. Determination of DAG generation from PC
PC hydrolysis was determined using lipid vesicles containing
[14C]-DPPC and cold DPPC to yield 45,000 dpm and 0.125 mM per
assay in a buffer containing 0.2% Triton X-100 and 0.1 M Tris
(pH 7.2). 100 μl of these lipid vesicles was added to 100 μl of treated
Syn or DRMs (200 μg of protein) in a ﬁnal volume of 200 μl. The reac-
tion was carried out at 37 °C for 20 min and stopped by the addition
of 5 ml of chloroform:methanol (2:1, v/v). Blanks were prepared
identically, except that membranes were boiled for 5 min before
use. Lipids were extracted and separated as described below [11,19].
To evaluate the contribution of PLD pathway to DAG formation, the
enzyme reaction was carried out in the presence of 2% EtOH [11,19].
To evaluate the contribution of PLD1 and PLD2 isoforms, Syn were
preincubated with their speciﬁc inhibitors (0.15 μM EVJ and 0.5 μM
APV) as described above.
2.5. [14C]-DAG isolation and quantiﬁcation
After the enzyme reaction, lipids were extracted as previously de-
scribed [11]. Brieﬂy, the lipid extract was washed with 0.2 volumes of
0.05% CaCl2 and the lower phase was obtained after centrifugation at
900 g for 5 min. Diacylglycerol (DAG) was then separated by
one-dimensional thin-layer chromatography (TLC) using silica gel G
plates (Merck) in a mobile phase consisting of hexane:diethyl ether:
acetic acid (50:50:2.6, v/v). PC was retained at the spotting site. Lipids
were visualized by exposure of the plate to iodine vapors and DAG
spots were scraped off the plate and radioactivity was determined
by liquid scintillation as previously described [11,19].
2.6. Lipid phosphorus measurement
In order to determine lipid phosphorus (lipid P), phospholipids (PLs)
were visualized by exposure of the plate to iodine vapors and lipid PwasFig. 1. PLD1 and PLD2 contributions to DAG generation elicited by iron-induced oxidative str
ence of the vehicle (DMSO), EVJ (0.15 μM) or APV (0.5 μM) at 37 °C for 10 min. After preinc
1 h. Enzyme reaction was started by adding 100 μl of preincubated Syn (200 μg protein)
45,000 dpm and 0.125 mM per assay, in the presence or in the absence of EtOH (2%). After 2
isolated and [14C]-DAG was separated and quantiﬁed as described in Materials and methods
signiﬁcant differences with respect to the vehicle condition (***pb0.001; **pb0.01).determined in each spot (and previously in total lipid extracts) using
the chemicals and reactions described by Rouser and collaborators [23].
2.7. Cholesterol measurement
Total cholesterol content was measured in aliquots of the lipid
extracts corresponding to 5 μg lipid P, using a commercial kit
(Colestat enzimático AA) from Wiener laboratory. The aliquots were
dried under N2 gas and resuspended in 100 μl of isopropyl alcohol,
and the manufacturer's instructions were subsequently followed.
Brieﬂy, the method is based on a series of enzyme reactions: ﬁrstly,
cholesterol esterase hydrolyzes cholesterol esters to cholesterol and
free fatty acids (FFA), and secondly, cholesterol oxidase oxidizes cho-
lesterol to cholesten-3-ona plus H2O2 which, in turn, reacts with
4-aminophenazone to generate a red compound (quinonimine) that
can be measured spectrophotometrically at 505 nm [19].
2.8. Lipid peroxidation assay
Lipid peroxidation wasmeasured using the thiobarbituric acid assay
as previously described [11,24]. Brieﬂy, after 1 h incubation in the pres-
ence of either Fe2+or vehicle, 1 ml of 30% trichloroacetic acid (TCA)was
added to 0.5 ml of Syn or DRMs (300 μg protein). Then, 0.1 ml of 5 N
HCl and 1 ml of 0.75% thiobarbituric acid were added. Tubes were
capped, the mixtures were heated at 100 °C for 15 min in a boiling
water bath and the samples were centrifuged at 1000 g for 10 min.
Thiobarbituric acid reactive substances (TBARS) were measured in the
supernatant at 535 nm and results were expressed as units of
absorbance at 535 nm per μmol of PLs (Abs 535 nm/μmol of PLs).
2.9. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis
(SDS-PAGE) and Western blot (WB) assays
Syn and DRMs samples were denatured with Laemmli sample
buffer at 100 °C for 5 min [25]. Equivalent amounts of synaptosomal,
DRM proteins and other fraction's proteins (30 μg) from adult
and aged animals were separated by sodium dodecyl sulfate-
polyacrylamide gel electrophoresis (SDS-PAGE) on 10% polyacryl-
amide gels and subsequently transferred to polyvinylidene ﬂuoride
(PVDF) membranes (Millipore, Bedford, MA, USA) which were
blocked with 10% bovine serum albumin (BSA) in TTBS buffer
[20 mM Tris–HCl (pH 7.4), 100 mM NaCl and 0.1% (w/v) Tween 20]
at room temperature for 2 h. Membranes were subsequently incu-
bated with primary antibodies [anti-Phospho-PKCα/βII (1:2000),ess. CC Syn were isolated from adult rats and preincubated in TBMmedium in the pres-
ubation, Syn were treated with 50 μM FeSO4 or ultrapure water (control condition) for
to 100 μl of lipid vesicles containing [14C]-DPPC and non-radiolabeled DPPC to yield
0 min incubation at 37 °C the enzyme reaction was stopped and lipids were extracted,
. Results are expressed as dpm [14C]-DAG×(mg protein×20 min)−1. Asterisks indicate
Fig. 2.Modulation of DAG formation by PKC andMEK/ERK pathways during iron-induced
oxidative stress. A) Modulation of DAG formation by PKC. Syn from adult and aged rats
were preincubated in TBM in the presence of vehicle (DMSO), PMA (1 μM) or BIM
(10 μM) for 10 min at 37 °C. After preincubation, Syn were treated with 50 μM FeSO4 or
ultrapure water (control condition) for 1 h. B) Modulation of DAG formation by MEK/
ERK pathway. Syn from adult and aged rats were preincubated in TBM in the presence
of vehicle (DMSO) or U0126 (25 μM) at 37 °C for 10 min. After preincubation, Syn were
treated with 50 μM FeSO4 or H2O (control condition) for 1 h. For A and B the enzyme re-
action and [14C]-DAG isolation and quantiﬁcation were performed as described in Fig. 1.
Results are expressed as dpm [14C]-DAG×(mgprotein×20 min)−1. Asterisks indicate sig-
niﬁcant differences with respect to the vehicle condition (*pb0.05).
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(1:1000), anti-Phospho-ERK1/2 (1:1000), anti-PKCα (1:1000) and
anti-PKCδ (1:1000) at room temperature for 2 h; anti-PLD1 (1:300),
anti-PLD2 (1:300), anti-PKD1 (1:500) and anti-Phospho-PKD1
(1:500) overnight at 4 °C], washed three times with TTBS and then
exposed to the appropriate HRP-conjugated secondary antibody
(anti-rabbit or anti-mouse) for 2 h at room temperature. Membranes
were washed again three times with TTBS and immunoreactive bands
were detected by enhanced chemiluminescence (ECL, Amersham Bio-
sciences) using standard X-ray ﬁlm (Kodak X-Omat AR).
2.10. Glutamate and GABA uptake assays
For the glutamate and GABA uptake assays, Syn were preincubated
with 0.15 μM EVJ, 0.5 μM APV, 10 μM BIM, 25 μM U0126 or Vehicle
(DMSO 0.0025%) for 10 min at 37 °C. After preincubation, oxidative
stress was induced by incubating Syn with 50 μM FeSO4 on ultrapure
water (control condition) for 1 h as previously described. Either
100 μl control or Fe2+-treated Syn (200 μg protein) were incubated
for 7 min at 37 °C with 100 μl of 4 mM CaCl2 TBM containing [3H]-
glutamate or [14C]-GABA (0.1 μCi/ml). The uptake reaction was
stopped by dilution with 800 μl of iced-cold TBM. Syn were then
pelleted, washed three times with 500 μl of iced-cold phosphate buff-
ered saline (PBS) and lysed in 400 μl of solution of 5% sodium dodecyl
sulfate (SDS) in PBS. The lysate was placed in scintillation vials and ra-
dioactivity was determined by liquid scintillation. Results were
expressed as dpm/mg protein×min.
2.11. Statistical analysis
Statistical analysis was performed using ANOVA followed by
Bonferroni's test to comparemeans. p-values lower than 0.05were con-
sidered statistically signiﬁcant. Data represent the mean value±SD of
three independent experiments using a pool of four animals on each
occasion. The WBs shown are representative of three analyses carried
out on samples from three independent experiments.
3. Results
3.1. PLD1 and PLD2 contributions to DAG generation elicited by
iron-induced oxidative stress
We have previously demonstrated that rat CC Syn incubated with
FeSO4 (50 μM) constitute an appropriate model for studying the ef-
fect of oxidative damage on synaptic endings [11,12]. In Syn exposed
to Fe2+ there was an increase in lipid peroxidation [measured as
thiobarbituric acid reactive substances (TBARS) formation], a reduced
glutamate uptake and mitochondrial function (measured as MTT re-
duction) and the plasma membrane integrity was also affected (eval-
uated as LDH leakage to the external medium) [11,12]. We have also
demonstrated that iron-induced oxidative stress stimulates DAG gen-
eration from PC in Syn from adult and aged rats due to the activation
of PC-speciﬁc phospholipase C (PC-PLC) and PLD/LPP pathways [11].
In the present work we further study the role of PLD1 and PLD2
isoforms in DAG formation and their participation in the activation
of PKD1, PKC and ERK pathways under iron-induced oxidative stress.
To study the particular role of PLD1 and PLD2, two recently devel-
oped isoform-speciﬁc inhibitors were used. Syn from adult rats were
preincubated with 0.15 μM EVJ (PLD1 inhibitor), 0.5 μM APV (PLD2
inhibitor) or vehicle (DMSO, 0.0025% ﬁnal concentration) for
10 min at 37 °C before treatment with iron or the same volume of
ultrapure H2O (control condition) for 1 h as described in Materials
and methods. To further analyze the contribution of PLD pathway to
DAG formation, the enzyme reaction was also carried out in the pres-
ence of 2% ethanol (EtOH). EtOH was added in order to avoid DAG
generation because in the presence of primary alcohols, PLDsexclusively catalyze a transphosphatidylation reaction yielding
phosphatidylalcohols instead of PA. Thus, phosphatidylalcohol gener-
ation blocks LPP action and prevents DAG formation from occurring
via PLD/LPP pathway [11,19]. After the treatment, [14C]-DAG forma-
tion from [14C]-DPPC was measured as described in Materials and
methods. Fig. 1 shows that under the control condition [14C]-DAG for-
mation was partially reduced to similar levels by EtOH and the PLD2
inhibitor, APV (25 and 30%, respectively). Iron treatment for 1h in-
creased [14C]-DAG by 65% and this rise was partially reduced by the
preincubation with EVJ and APV (16% and 23% respectively). Interest-
ingly, the sum of the effect of PLD1 and PLD2 inhibitors is in agree-
ment with the reduction of DAG formation observed in the presence
of 2% EtOH (38%). These results indicate that under the control condi-
tion only PLD2 is constitutively active in the synaptic ending whereas
both PLDs contribute to DAG formation under oxidative injury
conditions.
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iron-induced oxidative stress
To study the role of PKC on DAG generation during synaptic oxida-
tive injury, Syn from adult and aged rats were preincubated with
phorbol ester PMA (1 μM) or with PKC inhibitor BIM (10 μM). After
preincubation, Syn were treated with either FeSO4 (50 μM) or
ultrapure water (control condition) for 1 h. In Syn from adult rats nei-
ther PKC activation by PMA nor PKC inhibition affected DAG forma-
tion (Fig. 2A). In contrast, the presence of BIM completely abolished
the increase in DAG levels induced by iron in aged animals while
preincubation with PMA had no effect on DAG levels (Fig. 2A). Our re-
sults suggest a differential regulation of PLD pathways during iron-
induced oxidative injury in adult and aged animals. Syn from adult
rats were also preincubated with two different PKC inhibitors
Staurosporine (0.1 μM) and Chelerythrine (5 μM) neither of which
affected DAG levels (data not shown).
To further characterize the signaling pathways involved in DAG
generation, Syn were preincubated with the MEK inhibitor U0126
(25 μM), which is the immediate upstream regulator of ERK1/2. As
shown in Fig. 2B, while MEK kinase inhibition was observed not to af-
fect DAG formation from PC in Syn isolated from adult rats it
abolished the increase in DAG levels induced by iron in Syn from
aged rats (Fig. 2B). These results suggest that only in Syn from aged
animals the activation of DAG generating enzymes by oxidative stress
depends on the activation of MEK/ERK1/2 pathway.
3.3. Activation of PKD1, PKCα/βII, PKCδ and ERK1/2 by synaptic
iron-induced oxidative stress
In view of the rise in DAG levels generated by iron-induced oxida-
tive stress, we next studied the activation of several DAG respondingFig. 3. Activation of PKD1, PKCα/βII, PKCδ and ERK1/2 by FeSO4 exposure. CC Syn from adult
2 h. For Western Blot (WB) assays Syn proteins (30 μg) were resolved in a 10% SDS-PAGE an
and secondary antibodies as detailed in Materials and methods. Immunoreactive bands we
weights and data shown is a representative result of three independent experiments. The ba
protein expressed as ratio of control. Asterisks indicate signiﬁcant differences with respectproteins, namely PKD1, PKCα/βII and PKCδ. Moreover, since the
activation of RasGRP by DAG leads to the activation of the Ras/MEK/
ERK pathway, we also studied the activation of ERK1/2. To study
the activation of these signaling pathways, Western blot (WB)
assays were performed using primary antibodies raised against the
phosphorylated active forms of PKD1, PKCα/βII, PKCδ and ERK1/2.
Fig. 3 shows that in adult rats 2 h iron treatment strongly activates
PKD1 and ERK1/2 with respect to the control condition (120 and
600%, respectively). PKCα/βII (conventional PKCs) and PKCδ (novel
PKC) were also activated by oxidative stress (60 and 50%, respective-
ly). Loading controls were performed by detecting total PKD1, ERK1/
2, PKCα and PKCδ (Fig. 3). After 1 h of treatment with 50 μM FeSO4
ERK1/2 activation was 45% higher with respect to the control whereas
no increase in PKD1 phosphorylation was detected (data not shown).
3.4. Role of PLD isoforms and PKC on PKD1, PKCα/βII and ERK1/2
activation during iron induced oxidative stress
To study the participation of PLD1, PLD2 and PKCs in the activation
of PKD1, PKCα/βII and ERK1/2, Syn from adult and aged rats were
preincubated in the presence of EtOH (2%), PLD1 inhibitor EVJ
(0.15 μM), PLD2 inhibitor APV (0.5 μM) or PKC inhibitor BIM (10 μM).
In Syn from adult rats, EtOH, EVJ, APV and BIM strongly reduced
ERK1/2 activation elicited by iron-induced oxidative stress (1 h treat-
ment with FeSO4) (Fig. 4A, ﬁrst panel). The increase in PKCα/βII
phosphorylation after 1 h exposure to iron was also reduced by the
preincubation with EtOH, EVJ, APV and BIM (Fig. 4A, second panel).
The effect of these inhibitors on PKD1 phosphorylation was only stud-
ied after 2 h of oxidative insult on account of the fact that its activa-
tion was observed at this time (data not shown). After 2 h
treatment with FeSO4 ERK1/2, PKD1 and PKCα/βII activations was
also reduced by EtOH, EVJ, APV and BIM (Fig. 4B). In line with this,rats were treated with 50 μM FeSO4 (Fe2+) or ultrapure water (control condition, C) for
d transferred to a PDVF membrane. Membranes were blocked, incubated with primary
re detected by enhanced chemiluminescence. Numbers to the right indicate molecular
r graph shows the densitometry values of phosphorylated protein/non phosphorylated
to the control condition (***pb0.001; **pb0.01; *pb0.05).
Fig. 4. Role of PLD isoforms and PKC on PKD1, PKCα/βII and ERK1/2 activations during iron-induced oxidative stress in Syn from adult rats. CC Syn from adult rats were preincubated
in the presence of vehicle (DMSO), ethanol (2%), EVJ (0.15 μM), APV (0.5 μM) or BIM (10 μM) at 37 °C for 10 min. After preincubation, Syn were treated with 50 μM FeSO4 (Fe2+)
or ultrapure water (control condition, C) for 1 (A) or 2 h (B). C) Effect of PLD inhibitors on PKC activation. CC Syn from adult rats were preincubated in the presence of vehicle
(DMSO), EVJ (0.15 μM), APV (0.5 μM) or EVJ plus APV for 10 min at 37 °C. D) ERK1/2 activation by exogenous DAG. CC Syn from adult rats were treated with 0, 5 or 100 μM of
DOG for 2 h as described in Materials and methods. For A–D WB assays were performed as described in Fig. 3. Numbers to the right indicate molecular weights and data shown
is a representative result of three independent experiments. The bar graphs show the densitometry values of phosphorylated protein/non-phosphorylated protein expressed as
ratio of control. (a–d) indicate signiﬁcant differences (pb0.05).
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ilar to DAG levels generated under synaptosomal PLD activation con-
ditions) and 100 μM 1,2-dioctanoyl-sn-glycerol (DOG), 430 and 97%
respectively (Fig. 4D). In addition, PKCα/βII activation was also de-
pendent on PLD1 and PLD2 activities and the inhibition of classical
PKCs was observed to avoid ERK and PKD1 activation. These results
suggest that in adult Syn exposed to oxidative injury PLD1 and PLD2
are upstream effectors for ERK and PKD1 activation.
Under control conditions, PKCα/βII phosphorylation was partially
reduced by PLD2 inhibitor APV but was not affected by PLD1 inhibitor
EVJ (Fig. 4C). This is consistent with the decrease in DAG levels ob-
served under control conditions in the presence of APV, thus being in-
dicative of the presence of a constitutive activity of PLD2 (Fig. 1).
In contrast, in Syn from aged rats the presence of EtOH, EVJ, APV and
BIM did not prevent ERK1/2, PKD1 and PKCα/βII activations induced by
1 h treatment with FeSO4 (Fig. 5A) from occurring. After 2 h of treat-
ment with iron, ERK1/2 activation was reduced to control levels by
the preincubation with EtOH and PLD2 inhibitor APV and was also par-
tially reduced by BIM while it was not affected by PLD1 inhibitor EVJ
(Fig. 5B). In Syn isolated from aged rats, PKD1 activation was observed
earlier than in adults (after 1 h of treatment with FeSO4) and after 2 hFig. 5. Role of PLD isoforms and PKC on PKD1, PKCα/βII and ERK1/2 activations during iron-i
in the presence of vehicle (DMSO), ethanol (2%), EVJ (0.15 μM), APV (0.5 μM) or BIM (10 μM
or ultrapure water (control condition, C) for 1 (A) or 2 h (B) and WB assays were perform
shown is a representative result of three independent experiments. The bar graphs show the
trol. (a–d) indicate signiﬁcant differences (pb0.05).of oxidative injury PKD1 phosphorylation was reduced with respect to
the control condition (Fig. 5A and B, second panels). Moreover, in Syn
from aged animals exposed to oxidative damage for 2 h no differences
in PKCα/βII phosphorylation were detected between the different ex-
perimental conditions and the control condition (Fig. 5B). These results
demonstrate that the regulation and time course activation of PKD1,
PKCα/βII and ERK1/2 pathways in synaptic endings from aged animals
differ completely from those observed in adults. After 1 h of treatment
with iron ERK and PKD, activationwas not dependent on PLD or PKC ac-
tivities while after 2 h of treatment ERK activation seemed to be PLD2
and PKC dependent while it was not affected by PLD1 inhibition. After
the 2 h incubation period, no PKCα/βII activation was observed in
aged rats whereas PKD1 activation was found to decrease compared
to the control condition.
3.5. Effect of iron-induced oxidative stress on glutamate and GABA
uptake assays
Previous studies have characterized the impairment of glutamate
and gamma aminobutyric acid (GABA) transport after the exposure
of synaptosomes to oxidative insults [10,12,26,27]. Under ournduced oxidative stress in Syn from aged rats. CC Syn from aged rats were preincubated
) at 37 °C for 10 min. After preincubation, Syn were treated with 50 μM FeSO4 (Fe2+)
ed as described in Fig. 3. Numbers to the right indicate molecular weights and data
densitometry values of phosphorylated protein/total protein expressed as ratio of con-
Fig. 6. Effect of iron-induced oxidative stress on glutamate and GABA uptake assays. CC Syn from adult and aged rats were preincubated in the presence of vehicle (DMSO), EVJ
(0.15 μM), APV (0.5 μM), BIM (10 μM) or U0126 (25 μM) at 37 °C for 10 min. After preincubation, Syn were treated with 50 μM FeSO4 or H2O (control condition) for 1 h. Uptakes
were started by adding 100 μl of preincubated synaptosomal suspensions (200 μg protein) to 100 μl of buffer containing 0.1 μCi of [3H]-glutamate or [14C]-GABA per assay. After
7 min of incubation at 37 °C the uptakes were stopped by dilution in cold buffer and washed as described in Materials and methods. A) [3H]-glutamate uptake in Syn from
adult rats. B) [3H]-glutamate uptake in Syn from aged rats. C) [14C]-GABA uptake in Syn from adult rats. D) [14C]-GABA uptake in Syn from aged rats. Results are expressed as
dpm/mg protein×min. (a–d) indicate signiﬁcant differences (pb0.05).
2143M.V. Mateos et al. / Biochimica et Biophysica Acta 1823 (2012) 2136–2148experimental conditions [3H]-glutamate and [14C]-GABA uptakes were
signiﬁcantly reduced in adult Syn exposed for 1 h to FeSO4 (31% and
36%, respectively; Fig. 6A and C). Preincubation with PLD1 inhibitor
EVJ (0.15 μM) or with PKC inhibitor BIM (10 μM) did not affect
[3H]-glutamate uptake with respect to the vehicle condition. However,
preincubation with PLD2 inhibitor APV (0.5 μM) or with MEK inhibitor
U0126 (25 μM) reduced even more the uptake of [3H]-glutamate (45%
and 65%, respectively; Fig. 6A). In a different way, PLD1, PLD2, PKC
and MEK inhibitions did not affect the impairment in GABA transport
induced by iron treatment (Fig. 6C). These results suggest that in Syn
from adult animals PLD2 andMEK/ERK pathways participate in the pro-
tection against the deleterious effect of iron on the glutamate transport-
er (GLT). In contrast, none of the signaling pathways studied (PLD1,
PLD2, PKC and MEK/ERK) seemed to be involved in the impairment of
GABA uptake induced by the oxidative injury.
Fig. 6B shows that in Syn from aged rats iron treatment also re-
duced [3H]-glutamate uptake with respect to the control condition
(28%) and preincubation with PLD2 inhibitor APV (0.5 μM) reduced
even more the uptake of the neurotransmitter (45%). However,
PLD1 and PKC inhibition restored [3H]-glutamate uptake to the levels
observed under the control condition while MEK inhibition did not
modify impairment in glutamate uptake induced by oxidative stress
(Fig. 6B). These results suggest that also in Syn from aged animals
PLD2 protects GLT against the deleterious effect of iron whereas
PLD1 and some PKC isoforms produce a deleterious effect on the neu-
rotransmitter uptake. Our results also show that GABA uptake is se-
verely reduced in Syn from aged animals with respect to adults
(68%, Fig. 6D). In addition, in Syn from aged rats GABA transporter(GAT) was neither affected by oxidative damage nor modulated by
the signaling pathways studied (Fig. 6D).
3.6. DAG generation from PC in detergent resistant membranes (DRMs)
during iron-induced oxidative stress
Membrane rafts are small (10–200 nm), heterogeneous, sterol-
and sphingolipid-enriched domains that compartmentalize impor-
tant cellular processes such as cell adhesion and endocytosis and
they have been proposed as signal transduction platforms and as
key regulators of several signaling pathways [28,29]. One of the ﬁrst
methods originally used for the study of these domains was based
on their insolubility in non-ionic detergent such as Triton X-100 [22].
We have previously reported that the detergent resistant mem-
brane (DRM) fraction obtained from CC Syn evidenced typical charac-
teristics of membrane rafts, e.g. high content of sphingomyelin and
cholesterol and enrichment in caveolin, c-Src and ﬂotillin-1, three
proteins widely used as markers of membrane rafts. The DRM fraction
showed a more saturated fatty acid composition than synaptosomes,
with a great decrease in the content of polyunsaturated fatty acids
(PUFA) 20:4n-6 and 22:6n-3 (80%) and an enrichment in 16:0
(34%). Moreover, compared to adults, Syn and DRMs from aged ani-
mals also revealed a dramatic decrease in the fatty acids 20:4n-6
and 22:6n-3 [19]. We also demonstrated a differential localization of
PC-PLC and PLD isoforms in DRMs and entire Syn, i.e. whereas PLD1
and PC-PLC were concentrated in DRMs, PLD2 was excluded from
this fraction. Interestingly, in the DRM fraction DAG formation did
not decrease in the presence of EtOH, thus indicating that no PLD
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this fraction [19].
To further study the effect of iron-induced oxidative stress on DAG
generating pathways, PLD1 and PLD2 localizations in the DRM frac-
tion as well as their distribution in the fractions isolated from the su-
crose gradient were studied as a function of oxidative stress.
To assess these two items, DRMs were isolated from entire Syn ex-
posed to 50 μM FeSO4 or to the control condition for 1 or 2 h as de-
scribed in Materials and methods. The isolation of the DRM fraction
was based on their detergent insolubility at low temperature and
low buoyant density upon discontinuous sucrose density gradient
centrifugation. After a 20 h centrifugation at 120,000 g, three visible
ﬂoating bands (DRMs, B2 and B3) and a pellet were obtained. The
band containing DRMs was present in the 5–30% sucrose interface
(see schema in Fig. 8A) and [14C]-DAG generation from [14C]-DPPC
was measured as detailed in Materials and methods, either in the
presence of EtOH (2%) or the vehicle.
Fig. 7A shows that, in contrast to the results obtained in entire Syn,
in the DRM fraction from adult rats [14C]-DAG generation fromFig. 7. DAG generation from PC in detergent resistant membranes (DRMs) during
iron-induced oxidative stress. A) DAG generation from PC in DRMs exposed to FeSO4.
DRMs were isolated by their relative insolubility in cold Triton X-100 from CC Syn
from adult rats exposed to 50 μM FeSO4 or to the control condition (ultrapure water)
for 1 or 2 h. After treatment, the enzyme reaction was performed in the presence of
ethanol (2%) or vehicle (ultrapure water) as described in Fig. 1. [14C]-DAG isolation
and quantiﬁcation were performed as described in Fig. 1. Results are expressed as
dpm [14C]-DAG×(mg protein×20 min)−1. B) Lipid peroxidation was measured as
TBARS generation as described in Materials and methods. TBARS generation was eval-
uated in Syn and DRMs from adult and aged animals after exposure to 50 μM FeSO4 or
to the control condition (ultrapure water) for 1 h. Results are expressed as Abs
535 nm/μmol PLs. Asterisks indicate signiﬁcant differences between adults and aged
animals (**pb0.01; *pb0.05).[14C]-DPPC was not increased after 1 or 2 h treatment with FeSO4.
Likewise, no differences were observed in the presence of 2% EtOH
(Fig. 7A). These results indicate that DAG generation in the mem-
brane raft fraction is not affected by oxidative stress in spite of the en-
richment in PLD1 and PC-PLC isoforms previously reported in these
microdomains [19].
Lipid peroxidation (measured as TBARS formation) was greatly in-
creased in Syn from adult and aged rats exposed for 1 h to FeSO4 (370
and 770% with respect to the control condition) (Fig. 7B). However,
DRM fractions isolated from adult and aged rats showed no increase
in lipid peroxidation after iron-induced oxidative stress (Fig. 7B).
These results are in accordance with the more saturated fatty acid
composition previously reported for the membrane raft fraction [19].
On the other hand, lipid peroxidation levels in both fractions isolated
from aged animals (Syn and DRM) were lower than those observed
in adult animals, which is also in agreement with the decrease in
PUFA previously reported in aged animals compared to adults [19].
As described above, three ﬂoating bands (DRMs, B2 and B3) and a
pellet were obtained from adult Syn exposed to FeSO4 or to the con-
trol condition for 1 h (see schema in Fig. 8A). The protein content of
each fraction was determined and equivalent amounts of proteins
(30 μg) were resolved by SDS-PAGE. The presence of PLD1, PLD2
and Flotillin-1 in the different fractions was determined by WB as de-
scribed in Materials and methods.
PLD1 and Flotillin-1 were enriched in DRMs and in the second
ﬂoating band (B2) while PLD2 was enriched in the pellet and was
completely excluded from the ﬂoating bands (DRMs, B2 and B3).
Iron treatment induced an enhanced localization of PLD1 in DRMs
and in B2 whereas Flotillin-1 localization in DRMs was decreased.
Furthermore, PLD2 distribution was not affected by iron treatment
(Fig. 8A) while FeSO4 exposure induced no changes in the total pro-
tein distribution among the sucrose gradient nor in the cholesterol
content of Syn and DRMs (Fig. 8B and C, respectively).
4. Discussion
Synaptic signaling plays important roles in modulating the activity
of neuronal circuits and neuronal survival. In this work, we investi-
gate the regulatory mechanisms involved in DAG generation elicited
by PLD activation under synaptic oxidative stress.
Previous results from our laboratory have demonstrated that oxi-
dative stress induced by free iron stimulates the generation of the
lipid messenger DAG from PC in Syn from adult and aged rats. More-
over, the increase in phosphatidylethanol (PEtOH) levels in synapto-
somes exposed to free iron corroborated the activation of PLDs [11].
In this connection, PLD activity has been shown to be activated by a
fragment of amyloid beta (Aβ 25–35) in neuronal LA-N-2 cells and
it has been also shown that Aβ 1–40 increases PLD activity in hippo-
campal slices in a time course that resembles LDH release and neuro-
toxicity [30]. An increased PLD activity has also been found in
post-mortem brains from Alzheimer's patients [31,32].
Since both PLD isoforms are able to transphosphatidylate and gen-
erate phosphatidylalcohols, PLD1 and PLD2 activities are not distin-
guishable by PEtOH measurement. We therefore used two novel
isoform-speciﬁc inhibitors for PLD1 (EVJ) and PLD2 (APV) in order
to further study the participation of each isoform in DAG generation
induced by free iron. These two novel inhibitors are a very useful
and promising tool to discriminate between PLD1 and PLD2 activities
in cellular-free systems as synaptosomes, in which other strategies,
such as interference RNA, cannot be used [33,34]. The use of EtOH,
EVJ (PLD1 inhibitor) and APV (PLD2 inhibitor) demonstrated that
under control conditions basal PLD2 is responsible for DAG formation
in CC Syn. This ﬁnding is consistent with the higher basal activity of
PLD2 compared to that of PLD1 observed in a wide variety of tissues
[6,35]. However, in Syn exposed to oxidative stress the sum of the ef-
fect of both inhibitors is coincident with the decrease observed in the
Fig. 8. A) PLD1, PLD2 and Flotillin-1 distribution in the sucrose gradient used for DRMs isolation. DRMs and the subsequent fractions of the gradient (B2, B3 and Pellet) were isolated
from Syn from adult rats exposed to 50 μM FeSO4 or to the control condition (ultrapure water) for 1 h as described in Materials and methods. The presence of PLD1, PLD2 and
Flotillin-1 in the different fractions was determined by WB as described in Fig. 3. Numbers to the right indicate molecular weights. The bar graph shows the densitometry values
of protein content in the fraction with respect to synaptosomal content. Results expressed as arbitrary units. Asterisks indicate signiﬁcant differences with respect to control con-
dition (**pb0.01). B) Total protein distribution among the different fractions of the sucrose gradient. Total protein content in the different fractions was measured using the DC
protein assay kit from Bio-Rad. Results are expressed as percentage. C) Cholesterol content in Syn and DRMs. Total cholesterol was measured in Syn and DRMs using an enzymatic
method described in Materials and methods. Results are expressed as μg cholesterol/μg lipid P.
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generation triggered by iron-induced oxidative stress is due to the
activation of both PLD isoforms. In previous research from our labora-
tory, a similar decrease in DAG levels when Syn were incubated with
2% EtOH or DL-propranolol (used as LPP inhibitors) was observed
when measuring PC hydrolysis, thus conﬁrming the contribution of
PLD/LPP pathway and the effective conversion of PA into PEth [19].
In CC Syn from adult rats, the activation of ERK1/2, PKCα/βII and
PKD1 induced by oxidative stress is regulated by DAG produced by
PLD1 and PLD2 activities. In contrast, in Syn from aged animals, DAG
formation from PC is an event regulated by PKCs and MEK underoxidative injury conditions and DAG generated by PLD activities does
not participate in the regulation of ERK1/2, PKCα/βII and PKD1.
PKD isoforms are activated in response to numerous stimuli in-
cluding reactive oxygen species [36]. Moreover, PKD1 has been iden-
tiﬁed as a mitochondrial sensor for oxidative stress which regulates a
radical-sensing signaling pathway to mediate cellular detoxiﬁcation
and survival [37]. PKD1 gains full activity after phosphorylation by
novel PKC isoforms (PKCε, PKCθ, PKCπ, and PKCδ) although only
PKCδ regulates PKD1 activity in response to oxidative stress [38]. In
line with this, we found that PKD1 activation by oxidative stress in
CC synaptic endings is consistent with PKCδ activation.
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increasingly susceptible to oxidative stress [9,39]. Our results demon-
strate that aging induces signiﬁcant changes in the modulation of
DAG generating pathways from PC and in the regulation of the
above-mentioned signaling pathways in response to oxidative insult.
There is no general consensus on the crosstalk between PLD and
PKC during oxidative injury although most evidences point to PKC-
dependent PLD activation in the presence of Aβ or H2O2 [32,40]. This
is similar to ourﬁndings in aged animals. However, in adults, our results
suggest a differential role for PLDs on account of the fact that theymod-
ulate and regulate PKC and ERK activation under oxidative injury
conditions.
ERK1/2 signaling is known to play key roles in synaptic plasticity and
neuronal survival [41] and, together with other mitogen-activated
protein kinases (MAPKs), such as p38 and Jun kinase (JNK), it has
been involved in the pathogenesis of neurodegenerative diseases such
as AD and PD. It has thus been postulated that the balance between
ERK and JNK activation is a key factor in determining survival [42].
The present study provides, to our knowledge, the ﬁrst line of evidence
of an age-dependent differential crosstalk between PLD and ERK in the
synaptic ending.
Iron-induced oxidative injury was observed to signiﬁcantly reduce
glutamate and GABA uptake in Syn from adult animals. Our results
suggest that PLD2 and MEK/ERK pathway may counteract the delete-
rious effect of iron on GLT because the inhibition of these pathways
reduced even more glutamate uptake. The oxidative injury also re-
duced glutamate uptake in Syn from aged rats and PLD2 seemed to
exert the same protective role in GLT as in adult Syn. In contrast,
PLD1 and some PKC seemed to negatively affect GLT function under
oxidative stress conditions on account of the fact that the inhibition
of these pathways restored the uptake of glutamate to the levels ob-
served under the control conditions. This ﬁnding suggests, for the
ﬁrst time, a role played by PLDs in the regulation of glutamate trans-
porters in the synaptic endings exposed to oxidative injury.Fig. 9. Schematic view of signaling events elicited by oxidativeIntriguingly, none of the signaling pathways studied (PLD1, PLD2,
PKC and MEK/ERK) seem to be involved in the impairment of GABA
uptake induced by oxidative injury in adult Syn. In spite of the fact
that GABA is a signiﬁcant transmitter, little is known about the GABA
system during aging [43]. Our results show that GABA uptake is
severely affected in CC Syn from aged rats with respect to adults
and that the uptake of this neurotransmitter was not modulated by
PLDs, PKCs or MEK/ERK pathway. In line with this, previous reports
demonstrated that presynaptical alterations in the GABA system are
correlated with aging in the frontal cortex of the human brain [43].
On the other hand, there is no general agreement about where
PLD1 and PLD2 are localized in cells due to differences in cell type
and methodology [1]. We have previously demonstrated a differential
localization of DAG generating pathways from PC in DRMs and Syn
from adult and aged rats. Whereas PLD1 and PC-PLC were found to
be concentrated in DRMs, PLD2 was excluded from this fraction [19].
Furthermore, in the membrane raft fraction, DAG formation did
not decrease in the presence of EtOH, thus indicating that no
transphosphatidylation activity was detected in DRMs even though
PLD1 was concentrated in this fraction [19]. The association of PLD1
with caveolin has been described as an inhibitory mechanism for en-
zyme activity [44]. Moreover, the lack of cofactors in membrane rafts
such as the positive regulators of PLD activity, ARF, RhoA and cdc42,
could be another reason for non detectable PLD1 activity in these spe-
cialized domains. Preliminary data from our laboratory demonstrates
the absence of RhoA in DRMs (unpublished results). In the present
workwe further studied the effect of iron exposure onDAG generation
in the DRM fraction. In membrane rafts from adult rats DAG genera-
tion from PC was not increased by iron treatment, neither in the pres-
ence nor in the absence of EtOH, demonstrating that oxidative stress
does not increase DAG generation in the membrane raft fraction in
spite of the enrichment in PLD1. In addition, oxidative stress was ob-
served not to increase lipid peroxidation levels in the DRM fraction
but to induce an enhanced localization of PLD1 in thesemicrodomains.stress and their regulation in Syn from adult and aged rats.
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not increased in DRMs is in accordance with the more saturated
fatty acid composition previously reported about this fraction [19].
Likewise, PLD activity was not affected by oxidative stress in DRM
obtained from aged animals (data not shown). These results are in
agreement with the unchanged levels of lipid peroxides. It thus
seems that the activation of PLDs during oxidative stress could be trig-
gered by the increase in lipid peroxides in synaptic membranes, as it
has been previously shown [45,46]. Based on these ﬁndings, it could
be assumed that PLD1 localization in membrane rafts is a mechanism
to either prevent or close DAG signaling elicited by oxidative injury.
Taken together, ﬁndings from our study lead us to conclude that
both PLD isoforms (PLD1 and PLD2) differentially participate in the
iron-induced generation of the lipid messenger DAG in rat CC Syn
from adult and aged animals. Furthermore, whereas a strong correla-
tion between PLD activities and PKD1, ERK1/2 and PKCα/βII down-
stream modulation was observed in adult animals, this effect was
not observed in aged animals. In contrast, in senile Syn, DAG generat-
ed by PLDs was regulated by PKCs and ERK (Fig. 9). In addition, PLD2
and MEK/ERK pathway appear to play a protective role preventing, in
part, the deleterious effect of iron on GLT in adult animals. In aged an-
imals, PLD2 seems to have the same effect on the transporter activity
while ERK1/2 role seems to be impaired and PLD1 exerts a negative
modulation in GLT activity (Fig. 9). It can also be concluded that the
age-related changes reported in the present study are likely to partic-
ipate in the decline of cognitive functions and neuronal plasticity and
survival in the elderly.
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